Maxim John Levy Barnett

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsRespiratory diseasesNanotoxicology, health and safetyTraditional Chinese medicine and treatmentsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2026
Cardiovascular Outcomes Following Therapeutic Sclerostin Inhibition Compared With Alternative Anabolic Therapies: A Real-World Propensity Score-Matched Analysis.

|Apr 13, 2026
Cardiac arrest as the initial presentation of thyrotoxicosis in a young woman.

Maria Helena Siqueira Tavares de Melo, Maxim John Levy Barnett, Maria L M Rego

|Jul 18, 2025
Teprotumumab and sensorineural hearing loss: a propensity score-matched retrospective cohort study.

Maxim John Levy Barnett, Justin Lam, Mikaela Nikkola Jara-Tantoco

|Jul 10, 2025
Semaglutide therapy and iatrogenic thyrotoxicosis.

Maxim John Levy Barnett, Sarah Eidbo, Ana Rivadeneira

|Sep 04, 2024
Rectal thionamide administration in the setting of thyroid storm: a case report and review of the literature.

Maxim John Levy Barnett, Carlo Casipit, Sri Ram Teja Sathi

|Jun 09, 2021
The Unforeseen Diagnosis: Hyperparathyroidism-Jaw Tumour Syndrome Case Report and Review of the Literature.

Maxim Barnett, Farhan Ahmed, Radu Mihai

Pageof 1

Frequent Collaborators

1 joint publications

Radu Mihai

1 joint publications

Malik Asif Humayun